Where does Janssen Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Janssen Pharmaceuticals, Inc. ranks #584 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Janssen Pharmaceuticals, Inc. hold?

Janssen Pharmaceuticals, Inc. holds 769 US utility patents granted between 2015 and 2025, spanning 46 technology areas.

What is Janssen Pharmaceuticals, Inc.'s Innovation Score?

Janssen Pharmaceuticals, Inc. has an Innovation Score of 63.4 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Janssen Pharmaceuticals, Inc. focus on?

Janssen Pharmaceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 592 patents, ranking #13 of 6,058 assignees active in that subclass. Grants appear in 46 CPC subclasses total.

Is Janssen Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Janssen Pharmaceuticals, Inc.'s recent grant velocity is -7% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Janssen Pharmaceuticals, Inc.'s patents?

Janssen Pharmaceuticals, Inc.'s patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Janssen Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Janssen Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 769 granted patents across 46 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Janssen ranks #584 of 49,997 tracked US assignees by granted-patent volume, with 769 patents across 46 technology areas.

#584
of 49,997 US assignees by volume: Top 2%
by Innovation Score (63.4/100): 17.3
avg claims per patent: -7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R584 · US Corporation #584 · 769 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 769 grants
TOP-DECILE #584/49,997
PHOTO-FINISH Axis AB
CPC-WIDE A61P · 46 areas
INNOV-STRONG 63.4/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Axis AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Janssen’s 63.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 23.0 pts (36%) Velocity 6.1 pts (10%) Breadth 24.0 pts (38%) Claim depth 10.4 pts (16%)

Qualcomm Incorporated · highest

85
Saturn Licensing · near

63
China University of… · near

63
Janssen Pharmaceutic… · this assignee

63
Raven Industries · near

63
Case Western… · near

63
3D Lighting… · lowest

7

What this shows Janssen's Innovation Score is 63.4/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Janssen?

Each dot is one of Janssen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Janssen’s own 17.3 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Janssen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Janssen's grants concentrate

Janssen Pharmaceuticals, Inc. is a focused PatentsView assignee: 46 CPC subclasses with 77% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (95 grants) versus a trough of 63 in 2019. By volume, Janssen sits between Hitachi Construction Machinery Co., Ltd. and MediaTek Singapore Pte. Ltd..

Janssen's three-year grant acceleration

From 2019–2021 to 2022–2024, Janssen Pharmaceuticals, Inc. moved from 215 to 197 grants (0.92x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,423. See the growth leaderboard.

Hitachi Construct…

771
Novozymes A/S

770
Axis AB

769
Globalfoundries S…

769
Medtronic Minimed

769
Janssen Pharmaceu… ◀

769
Cochlear

768
Mellanox

766
Mediatek Singapor…

761

What this shows Janssen holds 769 patents at rank #584, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Janssen

By rank, the assignees closest to #584 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Janssen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Janssen, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Janssen ranks #13 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (63 here).

Raven Industries, inc. 63 China University of Mining and Technology-Beijing 63 Case Western Reserve University 63 Saturn Licensing LLC 63

Similar claim depth

Nearest assignees by average claims per patent (17.3 here).

Advanced Semiconductor Engineering, Inc. 17.3 avg THE Regents OF THE University OF Michigan 17.3 avg Smith & Nephew PLC 17.3 avg Staton Techiya LLC 17.3 avg

Janssen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Janssen Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	95	12.4%
2016	72	9.4%
2017	76	9.9%
2018	71	9.2%
2019	63	8.2%
2020	78	10.1%
2021	74	9.6%
2022	65	8.5%
2023	67	8.7%
2024	65	8.5%
2025partial year	43	5.6%

Which technologies does Janssen Pharmaceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 592

C07D - Heterocyclic Compounds 492

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 384

C07K - Peptides 105

Y02A - Technologies FOR Adaptation TO Climate Change 69

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 60

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 54

C07C - Acyclic OR Carbocyclic Compounds 34

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 32

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 26

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 24

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 22

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 21

A61B - DIAGNOSIS; SURGERY; Identification 13

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 10

Top 15 of 46 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Janssen Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Janssen Pharmaceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 77% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #584 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Janssen Pharmaceuticals, Inc. against Hitachi Construction Machinery Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 63.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.